Successful Modified Desensitization Therapy with Analog Insulin in an Individual with Severe Allergy to Multiple Insulin Preparations: A Case Report
Keywords:
insulin allergy, desensitization, excipients, T2 DM, insulin preparationsAbstract
We present a case of a 27-year-old lady with T2 DM who developed allergic reactions after commencement of insulin therapy. Trial with different types of insulin resulted in a series of allergic reactions ranging from urticarial rash to development of angioedema, bronchospasm and anaphylactic shock. She was successfully treated with a modified insulin desensitization protocol using rapid-acting insulin.
Downloads
References
Matheu V, Perez E, Hernández M, et al. Insulin allergy and resistance successfully treated by desensitisation with aspart insulin. Clin Mol Allergy. 2005;3:16. PMID: 16375762. PMCID: PMC1352375. https://doi.org/10.1186/1476-7961-3-16.
Wheeler BJ, Taylor BJ. Successful management of allergy to the insulin excipient metacresol in a child with type 1 diabetes: a case report. J Med Case Rep. 2012;6:263. PMID: 22937994. PMCID: PMC3469394. https://doi.org/10.1186/1752-1947-6-263.
Pföhler C, Müller CS, Hasselmann DO, Tilgen W. Successful desensitization with human insulin in a patient with an insulin allergy and hypersensitivity to protamine: a case report. J Med Case Rep. 2008;2:283. PMID: 18727824. PMCID: PMC2538533. https://doi.org/10.1186/1752-1947-2-283.
Raubenheimer PJ, Levitt NS. A case of generalised allergic reaction to human insulin. Journal of endocrinology, metabolism and diabetes of South Africa (JEMDSA). 2004; 9(1):18-20. https://doi.org/10.1080/22201009.2004.10872331.
Barranco R, Herrero T, Tornero P, et al. Systemic allergic reaction by a human insulin analog. Allergy. 2003;58(6):536–7. PMID: 12757463.
Heinzerling, L, Raile K, Rochlitz H, Zuberbier T, Worm M. Insulin allergy: clinical manifestations and management strategies. Allergy. 2008;63(2):148–55. PMID: 18186805. https://doi.org/10.1111/j.1398-9995.2007.01567.x.
Published
How to Cite
Issue
Section
License
Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).
To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.
A written agreement shall be emailed to the requester should permission be granted.